Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer
Phase 2
Terminated
- Conditions
- Non-small Cell Lung Cancer
- Registration Number
- NCT00099879
- Lead Sponsor
- Bristol-Myers Squibb
- Brief Summary
The purpose of this clinical research study is to learn if BMS-275183 can shrink or slow the growth of the cancer in subjects with non-small cell lung cancer (NSCLC). The safety of this treatment will also be studied.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Advanced or metastatic pretreated NSCLC
- Measurable disease
- Adequate hematologic, hepatic and renal functions
- ECOG Performance Status of 0-2
Exclusion Criteria
- Inability to swallow capsules
- Recent significant cardiovascular disease
- Woman who are pregnant or breastfeeding
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
Local Insitution
🇳🇱Groningen, Netherlands
Local Institution
🇬🇧Manchester, United Kingdom